| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2023-03-29 | BML Investment Partners, L.P. | Forte Biosciences, Inc. | 1,735,075 | 8.3% | EDGAR |
| SC 13D/A | 2023-02-21 | Camac Fund, LP | Forte Biosciences, Inc. | 1,812,712 | 8.6% | EDGAR |
| SC 13D/A | 2022-09-28 | Camac Fund, LP | Forte Biosciences, Inc. | 1,677,183 | 8.2% | EDGAR |
| SC 13D/A | 2022-09-22 | Funicular Funds, LP | Forte Biosciences, Inc. | 2,031,987 | 10.0% | EDGAR |
| SC 13G/A | 2022-09-12 | MORGAN STANLEY | Forte Biosciences, Inc. | 227,102 | 1.1% | EDGAR |
| SC 13D/A | 2022-08-24 | Funicular Funds, LP | Forte Biosciences, Inc. | 1,632,026 | 8.0% | EDGAR |
| SC 13D/A | 2022-08-18 | Camac Fund, LP | Forte Biosciences, Inc. | 1,451,786 | 7.1% | EDGAR |
| SC 13D/A | 2022-08-16 | BML Investment Partners, L.P. | Forte Biosciences, Inc. | 1,461,364 | 7.2% | EDGAR |
| SC 13D/A | 2022-08-09 | Camac Fund, LP | Forte Biosciences, Inc. | 1,451,786 | 9.8% | EDGAR |
| SC 13D | 2022-08-04 | ATG Fund II LLC | Forte Biosciences, Inc. | 1,462,000 | 9.9% | EDGAR |
| SC 13D | 2022-08-01 | Camac Fund, LP | Forte Biosciences, Inc. | 1,112,986 | 7.5% | EDGAR |
| SC 13D/A | 2022-07-19 | Funicular Funds, LP | Forte Biosciences, Inc. | 1,461,364 | 9.9% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Forte Biosciences, Inc. | 214,043 | 1.5% | EDGAR |
| SC 13D/A | 2022-07-07 | BML Investment Partners, L.P. | Forte Biosciences, Inc. | 1,342,391 | 9.1% | EDGAR |
| SC 13D | 2022-07-05 | Funicular Fund, LP | Forte Biosciences, Inc. | 1,111,870 | 7.5% | EDGAR |
| SC 13D | 2022-05-24 | BML Investment Partners, L.P. | Forte Biosciences, Inc. | 1,320,000 | 8.9% | EDGAR |
| SC 13G | 2022-05-04 | BML Investment Partners, L.P. | Forte Biosciences, Inc. | 888,757 | 6.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Point72 Asset Management, L.P. | Forte Biosciences, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | Forte Biosciences, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | PERCEPTIVE ADVISORS LLC | Forte Biosciences, Inc. | 0 | 0.0% | EDGAR |